arBtrage CAPITALIZING MARKETS checking… Sign in

Atea Pharmaceuticals, Inc.

AVIR Health Care Biotechnology: Pharmaceutical Preparations
$4.25
▼ -3.9% Today
as of Jun 7, 07:09 ET
Last 30 days -23.84% Apr 28 → Jun 05
$3.97 $4.44 $4.90 $5.36 $5.83 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$4.42
High
$4.43
Low
$4.24
Volume
$215,576
Avg Vol
$411,380
Mkt Cap
$379M
P/E (TTM)
Beta
52w High
$6.45
52w Low
$2.78
Div Yield
Shares Out
$80M

Overview

52-week range
$2.78
$6.45
40% of range
Avg surprise (last 2)
+16.8%
Avg reaction (last 2)
+5.2%
100% positive
Latest IV / EM
289%
EM ±40.0% · $5 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.75$-0.65$-0.55$-0.44$-0.34 Actual $-0.34Actual $-0.40Actual $-0.75Actual $-0.48Actual $-0.37Actual $-0.40Est $-0.56Actual $-0.44Actual $-0.53Actual $-0.57Est $-0.60 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-45M$-42M$-39M$-36M$-33M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.57 $-0.60 +5.0% -42.5% +1.7% earnings
Tue Sep 30, 2025Sep 2025 $-0.53 financials
Mon Jun 30, 2025Jun 2025 $-0.44 financials
Mon May 12, 2025Mar/2025 $-0.40 $-0.56 +28.6% +8.8% earnings
Mon Sep 30, 2024Sep 2024 $-0.37 financials
Sun Jun 30, 2024Jun 2024 $-0.48 financials
Sun Mar 31, 2024Mar 2024 $-0.75 financials
Sat Sep 30, 2023Sep 2023 $-0.40 financials
Fri Jun 30, 2023Jun 2023 $-0.34 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-48M$-46M$-41M$-39M$-37M$-47M
Net income$-45M$-42M$-37M$-34M$-31M$-41M
EPS (diluted)$-0.57$-0.53$-0.44$-0.40$-0.37$-0.48

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$79M$96M$77M$88M$119M$65M$98M$243M
Inventory
Total current assets$263M$311M$336M$386M$434M$462M$487M$506M
Total assets$267M$315M$343M$392M$440M$465M$491M$510M
Long-term debt
Total liabilities$27M$27M$29M$26M$32M$34M
Total equity$234M$275M$316M$364M$411M$439M$459M$476M

Implied volatility — last 90 days

283%286%288%291%293% Jun 07 — IV 289% · EM ±40.0%

Sector peers